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Formation ofbile requires the coordinated function of two epithelial cell types:
hepatocytes, that are responsible for secretion of the major osmolytes and bil-
iary constituents and cholangiocytes that regulate the fluidity and alkalinity of
bile through secretion of osmolytes such as Cl- and HC03- Studies in isolated
cholangiocyte preparations have elucidated the basic transport mechanisms
involved in constitutive and stimulated secretory activities in the biliary epithe-
lium. Basolateral Na+/H+ exchanger and Na+:HCO- symporter mediate
HCO - uptake, while an apical cAMP-activated Cl-/HCO3- exchanger secretes
bicarbonate into the lumen. Cholangiocytes also possess a cAMP-stimulated
Cl- conductance (CFTR) and a Ca-activated Cl- channel, both likely located at
the apical membrane. Cholangiocyte secretory functions are regulated by a
complex network ofhormones mainly acting via the cAMP system. In addition,
recent data indicate that part of the regulation of ductular secretion may take
place at the apical membrane of the cholangiocyte through factors present into
the bile, such as ATP, bile acids and glutathione.
Primary damage to the biliary epithelium is the cause of several chronic
cholestatic disorders (cholangiopathies). From a pathophysiological point of
view, common to all cholangiopathies is the coexistance ofcholangiocyte death
and proliferation and various degrees of portal inflammation and fibrosis.
Cholestasis dominates the clinical picture and, pathophysiologically, may initi-
ate or worsen the process. Alterations in biliary electrolyte transport could con-
tribute to the pathogenesis of cholestasis in primary bile duct diseases. Cystic
Fibrosis-related liver disease represents an example of biliary cirrhosis sec-
ondary to a derangement ofcholangiocyte ion transport. Most primary cholan-
giopathies recognize an immune-mediated pathogenesis. Cytokines, chem-
okines, and proinflammatory mediators released in the portal spaces or pro-
duced by the cholangiocyte itself, likely activate fibrogenesis, stimulate apop-
totic and proliferative responses, and alter the transport functions of the epithe-
lium.
The formation of bile requires the coordinated function of two epithelial cell types
that should be viewed as forming a functional bile secretory unit. Hepatocytes are respon-
sible for production of the canalicular bile, and for secretion of the major osmolytes and
biliary constituents, such as bile acids, lipids, glutathione, organic cations and anions,
xenobiotics, proteins andelectrolytes. Cholangiocytes, located downstream, determine the
fluidity and alkalinity of hepatocellular bile through absorbitive/secretory processes.
These functions are regulated by a complex network ofhormones and mediators the inter-
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action ofwhich results in net secretion or absorbtion. In addition, some ofthe compounds
secreted by hepatocytes are likely able to signal to the biliary epithelium. The intrahepat-
ic biliary tree can thus be considered as a critical site for rapid regulation of bile volume
and composition [1-5].
Although cholangiocytes are relatively few in number as compared to hepatocytes,
they seem to be very effective secretory cells, since, in humans, are responsible for 30 per-
cent ofbile volume, depending on the physiologic conditions [5]. Cholangiocytes perform
this task trough secretion of osmolites such as Cl- and HCO3- that establish a transep-
ithelial potential difference and an osmotic gradient that drive into the lumen Na+ and
water through the paracellular pathway and water selective channels [6, 7], respectively.
Still in the 1960s, it was demonstrated that secretin hydrocholeresis originated from the
bile ducts and was associated with reciprocal changes in Cl- and HC03- concentration.
Indeed, in basal conditions, Cl- and HC03- concentrations in bile are similar to plasma,
but there is a fall in Cl- concentration and a rise in HCO3- concentration, up to 70 mM,
consistent with the operation of an apical Cl-/HCO3- exchange [1, 8].
Studies in isolated cholangiocyte preparations [9, 10] have elucidated the basic trans-
port mechanisms involved in constitutive and stimulated secretory activities in the biliary
epithelium In rat biliary epithelial cells, a basolateral Na+/H+ exchanger [11, 12] (the
NHE-I isoform [13], and an electrogenic Na+:HCO3- symporter mediate acid extrusion.
In human biliary cholangiocytes, an electroneutral Na+-dependent Cl-/HCO3- exchanger
[14], rather than the electrogenic Na+:HCO3- symporter mediates HCO3- influx into the
cell. A basolateral Na+-K+-ATPase [15] maintains the Na+ gradient required for operation
ofthe above acid/base transporters. Accumulation ofHC03- within the bile duct cell can
also occur through carbonic anhydrase catalyzed hydration ofCO2 into the duct cell, fol-
lowed by backward transport ofprotons on Na+/H+exchange or H+ pumps. In both human
and rat cholangiocytes [11, 12, 14] once accumulated inside the cell, HC03- is secreted
into the biliary lumen by a cAMP-activated Cl-/HC03- exchanger (theAE-2 isoform [14,
16]) that has been localized to the apical membrane by both morphologic and functional
criteria. This is the only acid/base transporter clearly identified in the apical membrane,
however, apical Na+/H+ exchange isoforms (NHE-2 and NHE-3) are known to be
expressed in Na+ reabsorbing epithelia, including the gallbladder [17, 18]; by RT-PCR,
expression ofNHE-2 mRNA was reported in freshly isolated cholangiocytes [19]: an api-
cal Na+-dependent, amiloride inhibitable H+ efflux mechanism was recorded in microp-
erfused biliary ductules (J.L. Boyer, personal communication).
As in other secretory epithelia, in both human and rat cholangiocytes, basolateral Cl-
uptake involves bumetanide-sensitive Na+/K+/2Cl- cotransport and bumetanide inhibits
luminal swelling induced by forskolin in bile duct units [20]. Cholangiocyte Cl- efflux
pathways have been studied by patch clamp techniques. Cholangiocytes possess a cAMP-
stimulated Cl- conductance [21] with electrophysiological features similar to the cystic
fibrosis transmembrane conductance regulator (CFTR)b [22] and CFTR has been detect-
ed at the apical membrane of rat and human bile duct cells also by immunohistochemical
techniques[21, 23]. In addition, a Ca2+-activated Cl- channel [21, 24] is likely located at
the apical membrane. Extracellular ATP, that has been shown to increase cytosolic Ca2+
levels and to stimulate Cl- efflux in cholangiocyte cell lines [25], is among its physiolog-
ic agonists [24]. Cholangiocytes also possess a Ca2+- and cAMP- insensitive high con-
ductance anion channel, inhibited by pertussis toxin sensitive GTP-binding proteins [26,
27], but its physiologic role and membrane location are presently unknown. Finally, a
basolateral barium sensitive K+ conductance provides a leak pathway for K+ accumulat-
ed and maintains the membrane hyperpolarization needed to provide the driving force for
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inhibits K+ channels) together with bumetanide blocks the luminal expansion induced by
forskolin [20].
Secretin receptor is coupled to adenyl cyclase and it is well established that cAMP is
the second mediator of secretin [28]. Secretin and cAMP administration to cholangiocyte
cell lines activate low conductance Cl- selective channels [29], likely the CFTR. Although
Cl- is nine times more permeable that HCO3- through these channels, ion fluxes will actu-
ally depend on the magnitude of the respective electrochemical driving forces [30].
However cAMP did not increase HCO3- efflux in cells pretreated with DIDS, an inhibitor
ofCl-/HCO3- exchanger, but not ofCFTR, suggesting that, contrary to the airways epithe-
lium, no substantial Cl- conductance is operated by cAMP-activated Cl- channels in the
biliary epithelium [31].
Cyclic AMP and secretin administration increase Cl-/HCO3- exchange activity [12],
but these effects are inhibited by the Cl- channel inhibitor NPPB [12], suggesting that
Cl-/HCO3- exchange activation requires functional cAMP-sensitive Cl- conductances.
Contrary to CFTR, stimuli regulating Cl-/HCO3- exchange are not well established. In all
systems studied, intracellular alkalinization, increases the activity ofthe AE-2 isoform of
Cl-/HC03- exchange, a feature that distinguishes it from AE-1 [32]. Cyclic AMP admin-
istration to hepatocytes and cholangiocytes increase Cl1-/HC03- exchange activity, how-
ever this effect appears to be microtubule-dependent in hepatocytes [33, 34] and Cl- chan-
nel dependent in cholangiocytes [12]. Interestingly, when targeted to the basolateral mem-
brane, i.e., opposite to CFTR, AE-2 appears to lack the ability to be stimulated by cAMP
[13] and in cystic fibrosis pancreatic HC03- secretion is impaired [35]. Thus, association
of Cl-/HCO3- exchange with CFTR appears mandatory for cAMP-dependent HC03-
efflux. Studies in microdissected rat intrahepatic bile ducts and polarized bile duct units
have consistently shown that luminal pH is higher than that of the bathing medium and
increases following administration of cAMP agonists [36, 37]. The lumen expands fol-
lowing forskolin administration and both luminal alkalinization and expansion are inhib-
ited in the absence of HCO3- from the perfusate. In aggregate these findings confirm the
role ofCl- channels and Cl-/HCO3- exchanger as the main mechanisms for ductal biliary
fluidification and alkalinization, however they do not establish the mechanistic relation-
ship between Cl- and HCO3- transport.
When cAMP agonists are administered to secretory epithelial cells, a number of
events takes place: CFTR opens allowing Cl- efflux, Cl-/HCO3- exchange is stimulated,
K+ channels maintain the membrane hyperpolarization and exocytotic phenomena are
activated [12, 38]. CFTR plays a key role in all these changes [22, 39], in fact these
processes are defective in pancreatic duct cells expressing a mutated CFIR, but are
restored by complementation with wild-type CFIR. The capability to control other trans-
port proteins is a well recognized features ofCFTR [22] and it is also well known that the
multiple ionic defects ofcystic fibrosis, can not be explained only on the basis ofimpaired
Cl- transport. It has been suggested that CFTR, may regulate the activity of other ion
transporters through an autocrine mechanism involving extracellular ATP [40, 41]. For
example, in nasal and bronchial epithelia, extracellular ATP interacting with specific
receptors, opens outward rectifying Cl- channels and inhibits apical Na+ channels [41].
This hypothesis couldprovide a linkbetween CFTR activation and apical transport ofions
different from Cl- also in the biliary epithelium.
ExtracellularATP acts as a secretagogue in a number ofepithelia and several observa-
tions suggest that it may do so also in cholangiocytes. ATP is present into the bile in doses
able to activate purinergic receptors [42], and isolated cholangiocytes have been shown to
respond to ATP by activating Cl- channels [24]. In cholangiocyte cell lines extracellular
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44] and shifted to the right Na+/H+ exchange set point. Since both hepatocytes [45] and
cholangiocytes [42] appear to release purinergic nucleotides, extracellular ATP may act as
a paracrine signal promoting cellular HC03- uptake and thus transepithelial HC03- flux-
es. Interestingly, Na+/H+ exchange activity was increased also by agents raising cellular
cAMP levels, and this effect was inhibited by glybenclamide, a CFTR inhibitor that blocks
ATP release from the cell [41, 46], and by the specific extracellular ATP scavenger hexok-
inase. In aggregate, these data suggest that cAMP may increase Na+/H+ exchange through
ATP release from the cell and thatATP release is somehow regulated by CFTR. It is impor-
tant to underline that CFTR does not appear to possess the capability to act as an ATP chan-
nel [47], and its role in ATP release is likely purely regulatory. Given the direct pH1 depen-
dence ofcholangiocyte AE-2 [12], the rise in intracellular pHi, increases apical Cl-/HCO3-
exchange and further amplifies the secretory response that is also facilitated channel-medi-
ated efflux of Cl-. Consistent with this hypothesis, administration of ATP to cells treated
with cAMP further increased Cl-/HC03-exchange, an effect that was inhibited in the pres-
ence of amiloride [44].
This models requires the presence of purinergic receptors at the apical membrane of
the cholangiocyte. We have addressed this issue by studying the effects ofapical and baso-
lateral addition ofATP on Na+/H+ activity in a polarized rat cholangiocyte cell line [45].
In these studies (M. Strazzabosco unpublished results) apical administration of ATP, but
not adenosine significantly increased basolateral Na+/H+ exchanger activity; the pharma-
cological profile of the different agonists is consistent with the presence of apical P2u
receptors. Interestingly, Na+/H+ exchange appeared to respond very little to ATP when
administered from the basolateral side, but was clearly activated by adenosine and other
P1 receptors agonists such as NECA and R-PIA [49]. More generally, these data demon-
strate that part of the regulation of ductular secretion may take place at the apical mem-
brane of the cholangiocyte and that activation of an apical receptor can signal to a carrier
located at the opposite membrane and that there is a differential polarity ofregulatory sig-
nals acting on the same carrier.
Renewed interest in intrahepatic bile duct epithelium physiology and pathobiology
has been stimulated by the role played by this epithelium in several chronic cholestatic
disorders. Cholangiopathies ranges from conditions in which a normal epithelium is dam-
aged by disordered autoimmunity, infectious agents, toxic compounds or ischemia, to
genetically determined disorders arising from an abnormal bile duct biology, such as cys-
tic fibrosis or biliary atresia. From a pathophysiological point of view, common to all
cholangiopathies is the coexistance of cholangiocyte death and proliferation and various
degrees ofportal inflammation and fibrosis [4, 50]. Cholestasis dominates the clinical pic-
ture and, pathophysiologically, may initiate or worsen the process [51, 52].
Although the pathophysiological significance of the described ion transport mecha-
nisms is as yet not clear, alterations in biliary electrolyte transport could contribute to the
pathogenesis ofcholestasis in primary bile ductdiseases. From a speculative point ofview
cystic fibrosis liver disease is a very interesting model in that it represents an example of
biliary cirrhosis secondary to a derangement ofcholangiocyte ion transport. Low rates of
HCO3-, Cl- and fluid secretion from cholangiocytes may predispose the biliary epitheli-
um to toxic damages or to infections [53]. Indeed, CFTR is not expressed in hepatocytes
and bile duct cell damage can be demonstrated ultrastructurally well before hepatic
parenchymal cell damage appears [54]. However overt liver decompensation is clearly
much less frequent than pulmonary and pancreatic disease. The reason behind this differ-
ence is unclear, but in the case of the liver, other osmolites and regulatory factors secret-
ed by the hepatocytes, such as bile acids and glutathione and ATP, can probably sustain
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Most primary cholangiopathies recognize an immune-mediated pathogenesis, how-
ever mechanisms of cholestasis in these diseases are unclear. Cholestasis may be due to
obliteration ofbile ducts, but it is usually present before the onset ofductopenia and it can
be seen even in the absence ofcanalicular dilatation and bile plugs [4, 50-52]. Cytokines,
chemokines, and proinflammatory mediators released in the portal spaces [55] or pro-
duced by the cholangiocyte itself, likely activate fibrogenesis, stimulate apoptotic and pro-
liferative responses, and alter the transport functions of the epithelium. For example, the
low sensitivity ofprimary biliary cirrhosis to immune-suppressive therapy, the association
with secretory failure in other exocrine glands (sicca syndrome) and the beneficial effect
of choleretic bile acids, has been suggested to indicate that, in addition to immune-regu-
lation, biliary electrolyte transport could be impaired as well [56]. A defective expression
ofthe gene coding for theAE-2 apical anion exchanger has been reported in patients with
primary biliary cirrhosis [56]. AE-2 protein expression was also decreased both in liver
biopsies from primary biliary cirrhosis patients, as assessed by immunohistochemistry
[57]. Preliminary experiments have shown a decrease in cAMP-stimulated HC03- efflux
in cholangiocytes isolated from patients with primary biliary cirrhosis [58]. These data
suggest that alterations in biliary electrolyte transport may contribute to the pathogenesis
of cholestasis in primary disorders of bile ducts. Deranged cell function may be virus-
induced [59, 60] or be aparacrine/autocrine effect ofinflammatory mediators. On the con-
trary to cholestasis induced by bile duct ligation, where inflammation is minimal, most
ductopenic syndromes are associated to portal inflammation and the release of a number
of cytokines [55] that may have profound effects on epithelial cell function, altering its
transport properties [61-63]. For example, interferon-gamma has been shown to reduce
CFTR expression in T-84 colonic cells [61] and IL-6 decreases the expression of the Na+
dependent taurocholate transporter in hepatocytes [64].
Clearly, the field of immune regulation of cholangiocyte function will prove to be
very rewarding in the future [65]. Understanding the basics ofcholangiocyte transport will
soon lead to the development of cell-specific pharmacological or genetic agents [66-68]
that, by targeting specific cyto- or chemokines or transport systems involved in the differ-
ent steps ofthe inflammatory/fibrotic/cholestatic response, will provide effective and safe
treatment ofcholestatic diseases.
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